Do not take NEXAVAR if you have a specific type of lung cancer (squamous cell) and receive carboplatin and paclitaxel or if you are allergic to sorafenib or any of the other ingredients in NEXAVAR. Before starting NEXAVAR, tell your doctor if you have: allergies, heart problems (including a problem called “congenital long QT syndrome”) or chest pain, bleeding or bruising problems, high blood pressure, any planned surgical procedures, lung cancer or are being treated for lung cancer, kidney problems in addition to kidney cancer, or liver problems in addition to liver cancer. Tell your doctor if you are pregnant or plan to become pregnant and if you are breast-feeding or plan to breast-feed. It is not known if NEXAVAR passes into your breast milk. You and your doctor should decide if you will take NEXAVAR or breast-feed. You should not do both.
continue reading below »
NEXAVAR is indicated for a certain type of thyroid cancer called differentiated
thyroid carcinoma (DTC) that can no longer be treated with radioactive iodine
and is progressing. Learn more about NEXAVAR in DTC:
Hepatocellular carcinoma (HCC) is a type of liver cancer. When it cannot be treated with surgery it is known as unresectable HCC.
Learn about more treatment options, and working with a health care team.
Advanced renal cell carcinoma (RCC) is a type of kidney cancer.
Read about kidney cancer, treatment options available, and how to work with your health care team.
NEXAVAR has not been studied in children.
Treatment with NEXAVAR is proven to have certain benefits but can also carry serious side effects, so it is especially important to continually communicate with your health care team about what you can expect on your treatment plan.